Advaxis, Inc. (ADXSD)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Daniel J. O'Connor
Employees:
35
305 COLLEGE ROAD EAST, PRINCETON,, NJ 08540
732 545 1590

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Advaxis, Inc. focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer.

Data derived from most recent annual or quarterly report
Market Cap 435.828 Thousand Shares Outstanding1.816 Million Avg 30-day Volume 3.666 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.02
Price to Revenue81.4992 Debt to Equity0.0 EBITDA-23.907 Million
Price to Book Value0.6832 Operating Margin-10454.1502 Enterprise Value-4.559 Million
Current Ratio8.463 EPS Growth0.606 Quick Ratio7.651
1 Yr BETA 1.1993 52-week High/Low 1.57 / 0.24 Profit Margin-10462.0553
Operating Cash Flow Growth39.2715 Altman Z-Score-14.9443 Free Cash Flow to Firm -16.348 Million
View SEC Filings from ADXSD instead.

View recent insider trading info

Funds Holding ADXSD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADXSD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-07-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-24:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-06:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-05-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-04-07:
    Item 8.01: Other Events
  • 8-K: filed on 2022-04-01:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-12-30:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-22:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GITELMAN IGOR CHIEF ACCOUNTING OFFICER

    • Officer
    0 2021-02-11 0

    BERMAN RICHARD J

    • Director
    0 2020-05-04 0

    SIDRANSKY DAVID

    • Director
    0 2020-05-04 0

    APPEL RONI

    • Director
    0 2020-05-04 0

    PATTON JAMES P

    • Director
    0 2020-05-04 0

    HENDERSON MOLLY EXECUTIVE VICE PRESIDENT & CFO

    • Officer
    0 2020-05-04 0

    KHLEIF SAMIR N

    • Director
    0 2020-05-04 0

    BERLIN KENNETH A PRESIDENT AND CEO

    • Officer
    0 2020-05-04 0

    GUTIERREZ ANDRES EXECUTIVE VICE PRESIDENT & CMO

    • Officer
    0 2020-05-04 0

    PETIT ROBERT CHIEF SCIENTIFIC OFFICER

    • Officer
    231,206 2018-11-05 0

    LOMBARDO ANTHONY A INTERIM CEO

    • Officer
    81,852 2018-04-17 0

    BONSTEIN SARA CHIEF FINANCIAL OFFICER

    • Officer
    226,670 2018-03-29 0

    MCKEARN THOMAS J

    • Director
    0 2017-11-02 0

    RIDGE THOMAS J

    • Director
    0 2017-11-02 0

    ADAGE CAPITAL PARTNERS GP, L.L.C.

    ADAGE CAPITAL PARTNERS, L.P.

    ADAGE CAPITAL ADVISORS, L.L.C.

    ATCHINSON ROBERT

    GROSS PHILLIP

    • 10% Owner
    No longer subject to file 2017-10-11 0

    O'CONNOR DANIEL CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    618,352 2017-06-30 0

    MAYES, GREGORY T.

    • Director
    103,841 2016-12-30 0

    MAURO DAVID J CHIEF MEDICAL OFFICER

    • Officer
    166,271 2015-12-31 0

    FRENCH CHRISTY LEE VP-REGULATORY, MEDICAL AFFAIRS

    • Officer
    71,938 2014-12-31 0

    MOORE THOMAS A

    • FORMER DIRECTOR
    176,462 2014-07-17 0

    ROSENBLUM MARK J CHIEF FINANCIAL OFFICER

    • Officer
    113,774 2014-01-31 0

    ROTHMAN JOHN F EXEC VP OF SCIENCE AND OPS

    • Officer
    0 2011-11-08 0

    COBB FREDRICK D VICE PRESIDENT FINANCE

    • Officer
    0 2009-07-21 0

    WADE MARTIN R III

    • Director
    0 2006-03-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ADVAXIS INC ADXSD 2022-07-05 22:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 21:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 21:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 20:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 20:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 19:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 19:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 18:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 18:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 17:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 17:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 16:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 16:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 15:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 15:15:04 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 14:45:04 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 14:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 13:45:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 13:15:03 UTC -0.9008 2.4708 40000
    ADVAXIS INC ADXSD 2022-07-05 12:45:03 UTC -0.9008 2.4708 40000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments